Kolşisin Tedavisi Altındaki Ailevi Akdeniz Ateşi Tanısı ile Takip Edilen Çocuk Hastalarda Vitamin B12 Düzeylerinin Değerlendirilmesi

GİRİŞ ve AMAÇ: Ailevi Akdeniz Ateşi (AAA), ateş ve serözit atakları ile karakterize otoinflamatuvar bir hastalıktır. Düzenli olarak kullanılan günlük 1-2 mg kolşisin tedavisi ile AAA atakları azalmakta ya da tamamen geçmektedir. Bu çalışma ile pediatrik AAA hastalarında serum vitamin B12 düzeylerinin değerlendirilmesi, kolşisin tedavisinin süresi ve dozu ile vitamin B12 düzeyi arasında ilişki olup olmadığının araştırılması planlanmıştır.

Anahtar Kelimeler:

Ailevi Akdeniz Ateşi, kolşisin, vitamin B12, pediatrik

Evaluation of Vitamin B12 Levels in Pediatric Familial Mediterranean Fever Patients on Colchicine Treatment

PDF

___

1) Lidar M, Livneh A. Familial Mediterranean fever: clinical, molecular and management advancements. Neth J Med. 2007;65:318-24.
2) Goldfinger SE. Colchicine for familial Mediterranean fever. N Engl J Med. 1972;287:1302-20.
3) Shinar Y, Livneh A, Langevitz P, Zaks N, Aksentijevich I, Koziol DE, et al. Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever. J Rheumatol. 2000;27:1703-7.
4) Levy M, Spino M, Read SE. Colchicine: a state-of-the-art review. Pharmacotherapy. 1991;11:196-211.
5) Race TF, Paes IC, Faloon WW. Intestinal malabsorption induced by oral colchicine. Comparison with neomycin and cathartic agents. Am J Med Sci. 1970;259:32-41.
6) Webb DI, Chodos RB, Mahar CQ, Faloon WW. Mechanism of vitamin B12 malabsorption in patients receiving colchicine. N Engl J Med. 1968;279:845-50.
7) Rasmussen SA, Fernhoff PM, Scanlon KS. Vitamin B12 deficiency in children and adolescents. J Pediatr. 2001;138:10-7.
8) Yalçinkaya F, Ozen S, Ozçakar ZB, Aktay N, Cakar N, Düzova A, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology (Oxford). 2009;48:395-8.
9) Leung YY, Yao Hui LL, Kraus VB. Colchicine--Update on mechanisms of action and therapeutic uses. Semin Arthritis Rheum. 2015;45:341-50.
10) Stopa EG, O'Brien R, Katz M. Effect of colchicine on guinea pig intrinsic factor-vitamin B12 receptor. Gastroenterology. 1979;76:309-14.
11) Kuncl RW, Duncan G, Watson D, Alderson K, Rogawski MA, Peper M. Colchicine myopathy and neuropathy. N Engl J Med. 1987;316:1562-8.
12) Palopoli JJ, Waxman J. Colchicine neuropathy or vitamin B12 deficiency neuropathy? N Engl J Med. 1987;317:1290-1.
13) Yilmaz R, Ozer S, Ozyurt H, Erkorkmaz U. Serum Vitamin B12 status in children with familial mediterranean fever receiving colchicine treatment. HKJ Paediatr (new series). 2011;16:3-8
14) Akyuz SG, Erguven M, Hamzah OY. Do Vitamin B12 Levels Need to be Evaluated in FMF Cases Having Long Term Colchicine Treatment? Annals of Paediatric Rheumatology. 2012;1:139-42.
15) Gemici AI, Sevindik ÖG, Akar S, Tunca M. Vitamin B12 levels in familial Mediterranean fever patients treated with colchicine. Clin Exp Rheumatol. 2013;31:57-9.
16) Yesilova Z, Pay S, Oktenli C, Musabak U, Saglam K, Sanisoglu SY, et al. Hyperhomocysteinemia in patients with Behçet's disease: is it due to inflammation or therapy? Rheumatol Int. 2005;25:423-8.